Status:
COMPLETED
Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Localized Resectable Neuroblastoma
Localized Unresectable Neuroblastoma
Eligibility:
All Genders
Brief Summary
This laboratory study is looking at genes in participants with neuroblastoma or noncancerous conditions. Identifying genes related to cancer may help in the study of cancer. It may also help doctors p...
Detailed Description
OBJECTIVES: I. Perform a whole genome scan for association of neuroblastoma with single nucleotide polymorphisms (SNP) and SNP haplotypes. II. Identify true disease-associated SNP alleles using a cu...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient:
- Diagnosis of neuroblastoma
- Banked constitutional and genomic DNA within COG-ANBL00B1 Neuroblastoma Biology protocol or another COG Biology Protocol
- At least 1.0 ?g of DNA available
- Control (age, race, and gender-matched):
- No diagnosis of cancer
- May have other conditions, including any of the following:
- Asthma
- Inflammatory bowel disease
- Attention-deficit disorder
- Obesity
Exclusion
Key Trial Info
Start Date :
December 11 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
9350 Patients enrolled
Trial Details
Trial ID
NCT00436696
Start Date
December 11 2006
Last Update
August 7 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216
2
Childrens Oncology Group
Philadelphia, Pennsylvania, United States, 19104